This site makes use of Javascript, please enable your web browser to allow Javascript. Thank you.

Ninth Circuit Rules That Imperfect Methodology Used By Pharmaceutical Company Does Not Const…

September 10, 2012

Ninth Circuit Rules That Imperfect Methodology Used By Pharmaceutical Company Does Not Constitute a Securities Law Violation and Clarifies the Supreme Court's Decision in Matrixx